These differential chemokine profiles suggest potential biomarkers for distinguishing between ESCC and EAC, with CXCL12/CXCR4 axis being particularly prominent in ESCC and potentially representing a more specific therapeutic target (Table 2). Here, CXCL12 is linked to esophageal squamous cell carcinoma.